Ann E. McCullough

4.0k total citations
77 papers, 2.2k citations indexed

About

Ann E. McCullough is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Ann E. McCullough has authored 77 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 30 papers in Cancer Research and 20 papers in Pathology and Forensic Medicine. Recurrent topics in Ann E. McCullough's work include HER2/EGFR in Cancer Research (19 papers), Breast Cancer Treatment Studies (17 papers) and Breast Lesions and Carcinomas (14 papers). Ann E. McCullough is often cited by papers focused on HER2/EGFR in Cancer Research (19 papers), Breast Cancer Treatment Studies (17 papers) and Breast Lesions and Carcinomas (14 papers). Ann E. McCullough collaborates with scholars based in United States, United Kingdom and Switzerland. Ann E. McCullough's co-authors include Barbara A. Pockaj, Amylou C. Dueck, Nabil Wasif, Richard J. Gray, Ba D. Nguyen, Donald W. Northfelt, Karen S. Anderson, Heather E. Cunliffe, Xochiquetzal J. Geiger and Monica M. Reinholz and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ann E. McCullough

75 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann E. McCullough United States 26 1.2k 875 433 420 383 77 2.2k
Neslihan Cabıoğlu Türkiye 25 1.3k 1.1× 905 1.0× 346 0.8× 299 0.7× 882 2.3× 112 2.8k
Malini Harigopal United States 21 1.0k 0.9× 738 0.8× 672 1.6× 338 0.8× 303 0.8× 79 2.5k
Francis R. Spitz United States 25 1.1k 1.0× 530 0.6× 493 1.1× 413 1.0× 522 1.4× 55 2.4k
Emanuela Bonoldi Italy 23 738 0.6× 499 0.6× 801 1.8× 292 0.7× 341 0.9× 80 1.9k
Mauro Truini Italy 27 948 0.8× 311 0.4× 677 1.6× 468 1.1× 297 0.8× 101 2.6k
Elizabeth Hyjek United States 29 1.8k 1.5× 425 0.5× 1.1k 2.4× 356 0.8× 671 1.8× 68 3.6k
Konnie M. Hebeda Netherlands 27 883 0.8× 427 0.5× 524 1.2× 268 0.6× 1.3k 3.4× 93 2.5k
Sherri Z. Millis United States 25 1.1k 1.0× 421 0.5× 772 1.8× 852 2.0× 360 0.9× 93 2.3k
Carlos Alfaro Spain 28 2.2k 1.9× 344 0.4× 726 1.7× 403 1.0× 231 0.6× 57 3.7k
Diego Chowell United States 16 2.2k 1.9× 583 0.7× 877 2.0× 790 1.9× 176 0.5× 37 3.3k

Countries citing papers authored by Ann E. McCullough

Since Specialization
Citations

This map shows the geographic impact of Ann E. McCullough's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann E. McCullough with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann E. McCullough more than expected).

Fields of papers citing papers by Ann E. McCullough

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann E. McCullough. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann E. McCullough. The network helps show where Ann E. McCullough may publish in the future.

Co-authorship network of co-authors of Ann E. McCullough

This figure shows the co-authorship network connecting the top 25 collaborators of Ann E. McCullough. A scholar is included among the top collaborators of Ann E. McCullough based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann E. McCullough. Ann E. McCullough is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Speiser, Lisa, Janis E. Blair, Ami A. Shah, et al.. (2023). A Case of Sustained Viral Shedding of Mpox With Ocular Involvement Resulting in Vision Loss. Open Forum Infectious Diseases. 11(1). ofad632–ofad632.
3.
Gray, Richard J., Nabil Wasif, Patricia A. Cronin, et al.. (2019). Predictive factors of upstaging DCIS to invasive carcinoma in BCT vs mastectomy. The American Journal of Surgery. 217(6). 1025–1029. 11 indexed citations
4.
McDonald, Bradon R., Tania Contente‐Cuomo, Stephen‐John Sammut, et al.. (2019). Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer. Science Translational Medicine. 11(504). 201 indexed citations
5.
Lambertini, Matteo, Christine Campbell, Richard D. Gelber, et al.. (2019). Dissecting the effect of hormone receptor status in patients with HER2-positive early breast cancer: exploratory analysis from the ALTTO (BIG 2-06) randomized clinical trial. Breast Cancer Research and Treatment. 177(1). 103–114. 26 indexed citations
6.
Webb, Christopher, Heidi Kosiorek, Patricia A. Cronin, et al.. (2019). Are we choosing wisely in elderly females with breast cancer?. The American Journal of Surgery. 218(6). 1229–1233. 12 indexed citations
7.
8.
Perez, Edith A., E. Aubrey Thompson, Karla V. Ballman, et al.. (2015). Genomic Analysis Reveals That Immune Function Genes Are Strongly Linked to Clinical Outcome in the North Central Cancer Treatment Group N9831 Adjuvant Trastuzumab Trial. Journal of Clinical Oncology. 33(7). 701–708. 144 indexed citations
9.
Visscher, Daniel W., Marlene H. Frost, Lynn C. Hartmann, et al.. (2015). Clinicopathologic features of breast cancers that develop in women with previous benign breast disease. Cancer. 122(3). 378–385. 29 indexed citations
10.
Jacobs, Karen, Jana Cason, & Ann E. McCullough. (2015). The Process for the Formulation of the International Telehealth Position Statement for Occupational Therapy. International Journal of Telerehabilitation. 7(1). 21–32. 22 indexed citations
11.
Chang, James M., Ann E. McCullough, Amylou C. Dueck, et al.. (2015). Back to Basics: Traditional Nottingham Grade Mitotic Counts Alone are Significant in Predicting Survival in Invasive Breast Carcinoma. Annals of Surgical Oncology. 22(S3). 509–515. 18 indexed citations
12.
Perez, Edith A., E. Aubrey Thompson, S. Keith Anderson, et al.. (2014). Association of genomic analysis of immune function genes and clinical outcome in the NCCTG (Alliance) N9831 adjuvant trastuzumab trial.. Journal of Clinical Oncology. 32(15_suppl). 509–509. 9 indexed citations
13.
Dueck, Amylou C., Monica M. Reinholz, Xochiquetzal J. Geiger, et al.. (2013). Impact of c-MYC Protein Expression on Outcome of Patients with Early-Stage HER2+ Breast Cancer Treated with Adjuvant Trastuzumab NCCTG (Alliance) N9831. Clinical Cancer Research. 19(20). 5798–5807. 19 indexed citations
14.
Perez, Edith A., Amylou C. Dueck, Ann E. McCullough, et al.. (2013). Impact of PTEN Protein Expression on Benefit From Adjuvant Trastuzumab in Early-Stage Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the North Central Cancer Treatment Group N9831 Trial. Journal of Clinical Oncology. 31(17). 2115–2122. 89 indexed citations
15.
Holley, Tara, Elizabeth Lenkiewicz, Lisa Evers, et al.. (2012). Deep Clonal Profiling of Formalin Fixed Paraffin Embedded Clinical Samples. PLoS ONE. 7(11). e50586–e50586. 38 indexed citations
16.
McGhan, Lee J., Barbara A. Pockaj, Nabil Wasif, et al.. (2012). Atypical Ductal Hyperplasia on Core Biopsy: An Automatic Trigger for Excisional Biopsy?. Annals of Surgical Oncology. 19(10). 3264–3269. 78 indexed citations
17.
Perez, Edith A., Amylou C. Dueck, Ann E. McCullough, et al.. (2011). Predictability of Adjuvant Trastuzumab Benefit in N9831 Patients Using the ASCO/CAP HER2-Positivity Criteria. JNCI Journal of the National Cancer Institute. 104(2). 159–162. 57 indexed citations
18.
Reinholz, Monica M., Jeanette E. Eckel‐Passow, S. Keith Anderson, et al.. (2010). Expression profiling of formalin-fixed paraffin-embedded primary breast tumors using cancer-specific and whole genome gene panels on the DASL®platform. BMC Medical Genomics. 3(1). 60–60. 11 indexed citations
19.
Nguyen, Ba D. & Ann E. McCullough. (2002). Imaging of Merkel Cell Carcinoma. Radiographics. 22(2). 367–376. 62 indexed citations
20.
McCullough, Ann E., et al.. (2002). Nodular Sarcoidosis. New England Journal of Medicine. 346(25). 1970–1970. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neslihan Cabıoğlu Breakdown of academic impact, for papers by Malini Harigopal Breakdown of academic impact, for papers by Francis R. Spitz Breakdown of academic impact, for papers by Emanuela Bonoldi Breakdown of academic impact, for papers by Mauro Truini Breakdown of academic impact, for papers by Elizabeth Hyjek Breakdown of academic impact, for papers by Konnie M. Hebeda Breakdown of academic impact, for papers by Sherri Z. Millis Breakdown of academic impact, for papers by Carlos Alfaro Breakdown of academic impact, for papers by Diego Chowell
Rankless by CCL
2026